healthprotocol.wiki

Protocols Evidence Outcomes

medication-diabetes-insulin-degludec-daily-generic-generic

Outcomes

01
biomarker-glucose-fasting-serum-mg-per-dl-measured
1 evidence row
- anonymous_2017_n1_switched-from-lantus-to-tresiba-increased-morning-blood-sugar-and-a1c
02
biomarker-glucose-hemoglobin-a1c-serum-millimoles-per-mole-measured
1 evidence row
- anonymous_2017_n1_switched-from-lantus-to-tresiba-increased-morning-blood-sugar-and-a1c
03
biomarker-glucose-hemoglobin-a1c-serum-percent-measured
1 evidence row
- russell-jones_2023_rct_once-weekly-icodec-versus-once-daily-degludec-in-adults-with-type-1-diabetes
04
biomarker-glucose-hypoglycemia-severe-episodes-per-week-count-self-reported
1 evidence row
- russell-jones_2023_rct_once-weekly-icodec-versus-once-daily-degludec-in-adults-with-type-1-diabetes

Evidence

2rows

On this page

Permalink

/protocols/medication-diabetes-insulin-degludec-daily-generic-generic

healthprotocol.wiki

A community-driven, evidence-based health registry. Built for transparency.